Equity Analysis /
United States of America

US : Acceleron Pharma Inc. - XLRN | More Bullish Than Ever Following Meeting With Management; Raising PT to $160

    Danielle Brill
    Daniil Gataulin
    Daniil Gataulin

    Ph.D., Sr. Res. Assoc.

    CGS-CIMB
    19 January 2021
    Published by